BlackRock Health Sciences Trust (NYSE:BME) Declares $0.26 Monthly Dividend

BlackRock Health Sciences Trust (NYSE:BME) announced a monthly dividend on Thursday, September 10th. Shareholders of record on Friday, December 11th will be given a dividend of 0.2621 per share on Tuesday, December 22nd. This represents a c) annualized dividend and a yield of 7.1%. The ex-dividend date is Friday, December 11th.

BlackRock Health Sciences Trust Stock Down 0.6%

BME stock opened at $44.08 on Friday. BlackRock Health Sciences Trust has a 12 month low of $35.95 and a 12 month high of $46.42. The firm’s fifty day simple moving average is $44.19 and its 200-day simple moving average is $41.49.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada increased its stake in shares of BlackRock Health Sciences Trust by 0.5% during the first quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after purchasing an additional 684 shares in the last quarter. Jones Financial Companies Lllp purchased a new position in BlackRock Health Sciences Trust in the 1st quarter valued at about $386,000. Invesco Ltd. lifted its stake in BlackRock Health Sciences Trust by 0.5% in the 2nd quarter. Invesco Ltd. now owns 201,788 shares of the company’s stock valued at $7,357,000 after buying an additional 1,047 shares in the last quarter. First Trust Advisors LP boosted its holdings in BlackRock Health Sciences Trust by 108.1% in the 2nd quarter. First Trust Advisors LP now owns 14,930 shares of the company’s stock worth $544,000 after buying an additional 7,754 shares during the last quarter. Finally, NewEdge Advisors LLC boosted its holdings in BlackRock Health Sciences Trust by 8.5% in the 2nd quarter. NewEdge Advisors LLC now owns 14,185 shares of the company’s stock worth $517,000 after buying an additional 1,111 shares during the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.